Cargando…
Economic Burden of Comorbidities in Patients with Psoriasis in the USA
INTRODUCTION: This study assessed the comorbidity burden, healthcare resource utilization (HCRU), and costs associated with patients with moderate to severe psoriasis (PsO) compared with a matched cohort of the general population without PsO in the USA. METHODS: Comorbidity-related HCRU (incidence r...
Autores principales: | Wu, Jashin J., Suryavanshi, Manasi, Davidson, David, Patel, Vardhaman, Jain, Anuj, Seigel, Lauren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9823180/ https://www.ncbi.nlm.nih.gov/pubmed/36402940 http://dx.doi.org/10.1007/s13555-022-00832-9 |
Ejemplares similares
-
Early Discontinuation of Apremilast in Patients with Psoriasis and Gastrointestinal Comorbidities: Rates and Associated Risk Factors
por: Schmidt, Lana, et al.
Publicado: (2023) -
Treatment Patterns for Targeted Therapies, Non-Targeted Therapies, and Drug Holidays in Patients with Psoriasis
por: Armstrong, April, et al.
Publicado: (2022) -
Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
por: Feldman, Steven R., et al.
Publicado: (2015) -
Economic and Comorbidity Burden Among Moderate‐to‐Severe Psoriasis Patients with Comorbid Psoriatic Arthritis
por: Feldman, Steven R., et al.
Publicado: (2015) -
Clinical and Economic Burden of Mental Disorders Among Children With Chronic Physical Conditions, United States, 2008–2013
por: Suryavanshi, Manasi S., et al.
Publicado: (2016)